Information Library

Results for: Clinical and marketing materials - Clinical Monitoring - Europe - the Netherlands

In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions.  Search our library today.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Energizing Enrollment

    Case Study — October 4, 2011
    The rapid recruitment for this Phase III, open, randomized, controlled, multi-center study in adjuvant triple-negative breast cancer (TNBC) was completed two months earlier than planned.

  • Model-Based Drug Development

    Brochure — October 4, 2011
    Our industry-leading model-based drug development services boost the probability of success in the New Health by enabling you to make critical decisions earlier, optimizing your resources and returns.

  • Bypassing Barriers - Refractory Partial Epilepsy

    Case Study — February 2, 2011
    Despite a difficult and limited patient population, Quintiles randomized 388 patients (13 over target) 10 weeks ahead of schedule.

  • Parkinson's Disease - Ambitious Recruitment

    Case Study — February 1, 2011
    Quintiles provided project management, clinical monitoring, and more for a study of a drug for patients with early stage idiopathic Parkinson’s disease.

  • Epilepsy - Refining Recruitment

    Case Study — February 1, 2011
    Quintiles provided clinical monitoring and project management for a randomized, double-blind, parallel-group, placebo and comparator controlled multicenter study of Drug X in patients with epilepsy.

  • Global Response HIV

    Case Study — February 1, 2011
    Due to its global reach and extensive experience, Quintiles successfully managed 830 sites in 32 countries and recruited 14,521 patients.

  • A Lock on Consistency

    Case Study — February 1, 2011
    A double-blind, randomized, placebo-controlled trial evaluating the safety and efficacy of eplerenone in patients with heart failure following acute myocardial infarction.

  • Acute Coronary Syndrome - Tailored Solutions

    Case Study — February 1, 2011
    Find out how our experience in multi-national cardiovascular clinical trials helped this customer reach database lock 66 days after LPO.

Page 1 of 1 (8 results)

Subscribe to Email Based on Your Interests

Set preferences